These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26300645)

  • 1. Combined application of eicosapentaenoic acid and docosahexaenoic acid on depression in women: a meta-analysis of double-blind randomized controlled trials.
    Yang JR; Han D; Qiao ZX; Tian X; Qi D; Qiu XH
    Neuropsychiatr Dis Treat; 2015; 11():2055-61. PubMed ID: 26300645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
    Kelaiditis CF; Gibson EL; Dyall SC
    Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
    Sublette ME; Ellis SP; Geant AL; Mann JJ
    J Clin Psychiatry; 2011 Dec; 72(12):1577-84. PubMed ID: 21939614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 Fatty acids as Monotherapy in Treating Depression in Pregnant Women: a Meta- Analysis of Randomized Controlled Trials.
    Wei-Hong L; Cheng-Gui Z; Peng-Fei G; Heng L; Jian-Fang Y
    Iran J Pharm Res; 2017; 16(4):1593-1599. PubMed ID: 29552068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of omega-3 PUFAs in depression: A meta-analysis.
    Liao Y; Xie B; Zhang H; He Q; Guo L; Subramanieapillai M; Fan B; Lu C; McIntyre RS
    Transl Psychiatry; 2019 Aug; 9(1):190. PubMed ID: 31383846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
    Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
    PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
    Lin PY; Su KP
    J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.
    Mozaffari-Khosravi H; Yassini-Ardakani M; Karamati M; Shariati-Bafghi SE
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):636-44. PubMed ID: 22910528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial.
    Su KP; Lai HC; Yang HT; Su WP; Peng CY; Chang JP; Chang HC; Pariante CM
    Biol Psychiatry; 2014 Oct; 76(7):559-66. PubMed ID: 24602409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial.
    Ibrahim FAS; Ghebremeskel K; Abdel-Rahman ME; Ahmed AAM; Mohmed IM; Osman G; Elseed M; Hamed A; Rabinowicz AL; Salih MAM; Elbashir MI; Daak AA
    Epilepsy Behav; 2018 Oct; 87():32-38. PubMed ID: 30170260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the Effects of Docosahexaenoic and Eicosapentaenoic Acids on Inflammation Markers Using Pairwise and Network Meta-Analyses of Randomized Controlled Trials.
    Vors C; Allaire J; Mejia SB; Khan TA; Sievenpiper JL; Lamarche B
    Adv Nutr; 2021 Feb; 12(1):128-140. PubMed ID: 32790827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
    Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
    Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W
    Eur J Clin Nutr; 2018 Jun; 72(6):805-817. PubMed ID: 29284786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
    Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
    J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial.
    Zimmer R; Riemer T; Rauch B; Schneider S; Schiele R; Gohlke H; Diller F; Steinbeck G; Katus H; Senges J;
    J Clin Psychiatry; 2013 Nov; 74(11):e1037-45. PubMed ID: 24330904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the effects of docosahexaenoic and eicosapentaenoic acids on cardiovascular risk factors: Pairwise and network meta-analyses of randomized controlled trials.
    Fatahi S; Sohouli MH; da Silva Magalhães EI; da Cruz Silveira VN; Zanghelini F; Rahmani P; Kord-Varkaneh H; Sharifi-Zahabi E; Shidfar F
    Nutr Metab Cardiovasc Dis; 2023 Jan; 33(1):11-21. PubMed ID: 36319578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
    Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
    Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Efficacy and Biological Regulations of ω-3 PUFA-Derived Endocannabinoids in Major Depressive Disorder.
    Yang B; Lin L; Bazinet RP; Chien YC; Chang JP; Satyanarayanan SK; Su H; Su KP
    Psychother Psychosom; 2019; 88(4):215-224. PubMed ID: 31269506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.